Literature DB >> 2357340

Intra-blood-brain-barrier synthesis of immunoglobulins in patients with dementia of the Alzheimer type.

K Blennow1, A Wallin, P Davidsson, P Fredman, C G Gottfries, L Svennerholm.   

Abstract

Serum and cerebrospinal fluid (CSF) of 56 patients with dementia of the Alzheimer type (DAT) and 33 healthy controls were examined in order to investigate intra-blood-brain-barrier (intra-BBB) synthesis of immunoglobulins. Intra-BBB immunoglobulin G (IgG) synthesis was defined as an elevated IgG index (greater than 0.7) and/or presence of oligoclonal IgG in CSF but not in serum on isoelectric focusing, and intra-BBB immunoglobulin M (IgM) synthesis as an elevated IgM index (greater than 0.06). In total, 10 (18%) DAT patients displayed an intra-BBB immunoglobulin synthesis--five (9%) an IgG and five (9%) an IgM synthesis--but none among the controls. Also, the DAT patient group showed higher mean IgG and IgM indexes than the control group. These findings support the hypothesis that immunological mechanisms may play a role in the etiology and/or pathogenesis of Alzheimer disease, at least in a subgroup of patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357340

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  9 in total

1.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.

Authors:  N Rösler; I Wichart; K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

3.  Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease.

Authors:  Niels Andreasen; Kaj Blennow; Henrik Zetterberg
Journal:  Int J Alzheimers Dis       Date:  2010-12-19

Review 4.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

5.  Allergy influences the inflammatory status of the brain and enhances tau-phosphorylation.

Authors:  Heela Sarlus; Caroline Olgart Höglund; Bianka Karshikoff; Xiuzhe Wang; Mats Lekander; Marianne Schultzberg; Mircea Oprica
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

Review 6.  Involvement of blood mononuclear cells in the infertility, age-associated diseases and cancer treatment.

Authors:  Antonin Bukovsky
Journal:  World J Stem Cells       Date:  2016-12-26       Impact factor: 5.326

7.  Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis.

Authors:  Md Asiful Islam; Fahmida Alam; Mohammad Amjad Kamal; Siew Hua Gan; Teguh Haryo Sasongko; Kah Keng Wong
Journal:  Front Aging Neurosci       Date:  2017-08-02       Impact factor: 5.750

8.  Therapeutic B-cell depletion reverses progression of Alzheimer's disease.

Authors:  Ki Kim; Xin Wang; Emeline Ragonnaud; Monica Bodogai; Tomer Illouz; Marisa DeLuca; Ross A McDevitt; Fedor Gusev; Eitan Okun; Evgeny Rogaev; Arya Biragyn
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

Review 9.  Microglia receptors and their implications in the response to amyloid β for Alzheimer's disease pathogenesis.

Authors:  Deborah Doens; Patricia L Fernández
Journal:  J Neuroinflammation       Date:  2014-03-13       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.